Insider Transactions in Q1 2025 at Incyte Corp (INCY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.6%
|
$31,317
$73.47 P/Share
|
|
Jan 21
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,352
-15.57%
|
$889,344
$72.69 P/Share
|
|
Jan 15
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,692
-11.88%
|
$769,824
$72.46 P/Share
|
|
Jan 15
2025
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,672
-3.86%
|
$264,384
$72.46 P/Share
|
|
Jan 15
2025
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.26%
|
$65,376
$72.46 P/Share
|
|
Jan 15
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
3,158
-5.59%
|
$227,376
$72.46 P/Share
|
|
Jan 06
2025
|
Mohamed Khairie Issa EVP, Head of US Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
48,671
+50.0%
|
-
|